Prevention

Studies have supported that regular use of nonsteroidal anti-inflammatory
drugs (NSAIDs) such as ibuprofen (Advil, Motrin, Nuprin), naproxen sodium
(Aleve), and indomethacin (Indocin) may reduce AD risk by 30 to 60
percent.
Researchers are also studying the antioxidant affects of vitamin E and
selegiline hydrochloride in preventing brain damage caused by toxic free
radicals to slow the rate of progression of AD. Studies of estrogen replacement
therapy in menopausal women showed a reduced risk of developing
AD by 30 to 40 percent. In 2002, a synthetic form of beta-amyloid protein
(AN-1792) vaccine was being investigated in clinical trials.